323 related articles for article (PubMed ID: 17079165)
1. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Lin Z; Lei H; Cao P
Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
[TBL] [Abstract][Full Text] [Related]
2. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
3. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Wang D; Shi L
Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
[TBL] [Abstract][Full Text] [Related]
4. [Cloning, expression and purification of human TNF-related apoptosis-inducing ligand in Escherichia coli].
Yao GH; Luan JF; Ye D; Lei QH; Zhu PY; Jin J; Hou YY
Wei Sheng Yan Jiu; 2006 Nov; 35(6):697-700. PubMed ID: 17290744
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of recombinant sTRAIL expressed in Escherichia coli.
Xia XX; Shen YL; Wei DZ
Acta Biochim Biophys Sin (Shanghai); 2004 Feb; 36(2):118-22. PubMed ID: 14970907
[TBL] [Abstract][Full Text] [Related]
6. Cloning and purification of functionally active Fas ligand interfering protein (FIP) expressed in Escherichia coli.
Wisniewski P; Master A; Kaminska B
Acta Biochim Pol; 2008; 55(1):51-6. PubMed ID: 18204739
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase.
Gasparian ME; Ostapchenko VG; Yagolovich AV; Tsygannik IN; Chernyak BV; Dolgikh DA; Kirpichnikov MP
Biotechnol Lett; 2007 Oct; 29(10):1567-73. PubMed ID: 17609857
[TBL] [Abstract][Full Text] [Related]
8. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
[TBL] [Abstract][Full Text] [Related]
9. Construction and characterization of two versions of bifunctional EGFP-sTRAIL fusion proteins.
Shen J; Wu Y; Shi L; Liu J; Liu S; Guan Z; Yin Z
Appl Microbiol Biotechnol; 2007 Aug; 76(1):141-9. PubMed ID: 17562041
[TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
11. On-column refolding and purification of transglutaminase from Streptomyces fradiae expressed as inclusion bodies in Escherichia coli.
Liu XQ; Yang XQ; Xie FH; Song LY; Zhang GQ; Qian SJ
Protein Expr Purif; 2007 Feb; 51(2):179-86. PubMed ID: 16935525
[TBL] [Abstract][Full Text] [Related]
12. Purification, refolding, and characterization of recombinant LHRH-T multimer.
Raina K; Panda AK; Ali MM; Talwar GP
Protein Expr Purif; 2004 Sep; 37(1):8-17. PubMed ID: 15294275
[TBL] [Abstract][Full Text] [Related]
13. Improvement of expression level and bioactivity of soluble tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) by a novel zinc ion feeding strategy.
Sun AY; Shen YL; Yin JC; Zhang H; Tang YN; Wei DZ
Biotechnol Lett; 2006 Aug; 28(15):1215-9. PubMed ID: 16799759
[TBL] [Abstract][Full Text] [Related]
14. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
Jin H; Uddin MS; Huang YL; Teo WK
J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
[TBL] [Abstract][Full Text] [Related]
15. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
Kang H; Sun AY; Shen YL; Wei DZ
Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
[TBL] [Abstract][Full Text] [Related]
16. Production and purification of refolded recombinant Plasmodium falciparum beta-ketoacyl-ACP reductase from inclusion bodies.
Karmodiya K; Srivastav RK; Surolia N
Protein Expr Purif; 2005 Jul; 42(1):131-6. PubMed ID: 15939298
[TBL] [Abstract][Full Text] [Related]
17. Generation of a novel proform of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein that can be reactivated by matrix metalloproteinases.
Shin JN; Park SY; Cha JH; Park JY; Lee BR; Jung SA; Lee ST; Yun CW; Seol DW; Kim TH
Exp Cell Res; 2006 Nov; 312(19):3892-8. PubMed ID: 16996498
[TBL] [Abstract][Full Text] [Related]
18. Purification and on-column refolding of EGFP overexpressed as inclusion bodies in Escherichia coli with expanded bed anion exchange chromatography.
Cabanne C; Noubhani AM; Hocquellet A; Dole F; Dieryck W; Santarelli X
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(1):23-7. PubMed ID: 15722040
[TBL] [Abstract][Full Text] [Related]
19. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
20. Trimeric coiled-coil domain of human pulmonary surfactant protein D enhances zinc-binding ability and biologic activity of soluble TRAIL.
Wu X; Li P; Qian C; Li O; Zhou Y
Mol Immunol; 2009 Jul; 46(11-12):2381-8. PubMed ID: 19481806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
